These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 16964386)

  • 21. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
    Koensgen D; Mustea A; Klaman I; Sun P; Zafrakas M; Lichtenegger W; Denkert C; Dahl E; Sehouli J
    Gynecol Oncol; 2007 Nov; 107(2):266-73. PubMed ID: 17698176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer.
    Wilkinson SJ; Kucukmetin A; Cross P; Darby S; Gnanapragasam VJ; Calvert AH; Robson CN; Edmondson RJ
    Hum Pathol; 2008 Aug; 39(8):1197-204. PubMed ID: 18495208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer.
    Tchabo NE; Mhawech-Fauceglia P; Caballero OL; Villella J; Beck AF; Miliotto AJ; Liao J; Andrews C; Lele S; Old LJ; Odunsi K
    Cancer Immun; 2009 Aug; 9():6. PubMed ID: 19705800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and functions of transmembrane mucin MUC13 in ovarian cancer.
    Chauhan SC; Vannatta K; Ebeling MC; Vinayek N; Watanabe A; Pandey KK; Bell MC; Koch MD; Aburatani H; Lio Y; Jaggi M
    Cancer Res; 2009 Feb; 69(3):765-74. PubMed ID: 19176398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of TAG-72 in ovarian cancer and its correlation with tumor stage and patient prognosis.
    Ponnusamy MP; Venkatraman G; Singh AP; Chauhan SC; Johansson SL; Jain M; Smith L; Davis JS; Remmenga SW; Batra SK
    Cancer Lett; 2007 Jun; 251(2):247-57. PubMed ID: 17210225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma.
    Macor P; Mezzanzanica D; Cossetti C; Alberti P; Figini M; Canevari S; Tedesco F
    Cancer Res; 2006 Apr; 66(7):3876-83. PubMed ID: 16585216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of cancer/testis antigen OY-TES-1 attenuates malignant behaviors of hepatocellular carcinoma cells in vitro.
    Fu J; Luo B; Guo WW; Zhang QM; Shi L; Hu QP; Chen F; Xiao SW; Xie XX
    Int J Clin Exp Pathol; 2015; 8(7):7786-97. PubMed ID: 26339343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression.
    Simon I; Katsaros D; Rigault de la Longrais I; Massobrio M; Scorilas A; Kim NW; Sarno MJ; Wolfert RL; Diamandis EP
    Gynecol Oncol; 2007 Aug; 106(2):334-41. PubMed ID: 17498784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
    Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The relation of peroxisome proliferator activated receptorbeta and Epithelial Ovarian Carcinoma].
    Yang Y; Hou JQ; Ju HW; Yu ZH; Zhao ZW; Yang S; Yang HJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):630-2. PubMed ID: 17618585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.
    Karam AK; Stempel M; Barakat RR; Morrow M; Gemignani ML
    Gynecol Oncol; 2009 Mar; 112(3):490-5. PubMed ID: 19101713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
    Mezzanzanica D; Fabbi M; Bagnoli M; Staurengo S; Losa M; Balladore E; Alberti P; Lusa L; Ditto A; Ferrini S; Pierotti MA; Barbareschi M; Pilotti S; Canevari S
    Clin Cancer Res; 2008 Mar; 14(6):1726-33. PubMed ID: 18347173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
    Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
    Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The specific immune response to tumor antigen CP1 and its correlation with improved survival in colon cancer patients.
    Liu FF; Dong XY; Pang XW; Xing Q; Wang HC; Zhang HG; Li Y; Yin YH; Fant M; Ye YJ; Shen DH; Zhang Y; Wang S; Chen WF
    Gastroenterology; 2008 Apr; 134(4):998-1006. PubMed ID: 18395081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer.
    Brennan DJ; Ek S; Doyle E; Drew T; Foley M; Flannelly G; O'Connor DP; Gallagher WM; Kilpinen S; Kallioniemi OP; Jirstrom K; O'Herlihy C; Borrebaeck CA
    Eur J Cancer; 2009 May; 45(8):1510-7. PubMed ID: 19272768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of ovarian cancer patients who underwent incomplete surgical staging.
    Panprom P; Lertkhachonsuk R
    J Med Assoc Thai; 2008 Sep; 91(9):1323-30. PubMed ID: 18843859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human telomerase reverse transcriptase (hTERT) expression in borderline ovarian tumors: an immunohistochemical study.
    Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S
    J Med Assoc Thai; 2009 Mar; 92(3):308-14. PubMed ID: 19301721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Alteration of early growth response 1 expression in gastroenterological cancers and its biological significance].
    An J; Guo RF; Zhang L; Geng PL; Lü YY
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1384-9. PubMed ID: 18953875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reverse transcriptase-polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: potential value in molecular staging of prostate cancer.
    Joung JY; Yang SO; Jeong IG; Han KS; Seo HK; Chung J; Park WS; Lee KH
    Int J Urol; 2007 Jul; 14(7):635-43. PubMed ID: 17645609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of a putative ovarian oncogene, elongation factor 1alpha, isolated by panning a synthetic phage display single-chain variable fragment library with cultured human ovarian cancer cells.
    Sharma S; Tammela J; Wang X; Arnouk H; Driscoll D; Mhawech-Fauceglia P; Lele S; Kazim AL; Odunsi K
    Clin Cancer Res; 2007 Oct; 13(19):5889-96. PubMed ID: 17908984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.